Risvutatug
HS-20093 Antibody (GSK5764227 Antibody) is an antibody targeting B7-H3, which can be used to synthesize the ADC HS-20093. HS-20093 Antibody exhibits anti-tumor activity. HS-20093 Antibody can be studied in research for small cell lung cancer, relapsed or refractory osteosarcoma, and advanced solid tumors[1][2][3].
Product Specifications
CAS Number
3042848-87-0
Product Name Alternative
HS-20093 Antibody; GSK5764227 Antibody
UNSPSC
12352203
Target
ADC Antibody; CD276/B7-H3
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.55
Smiles
[Risvutatug]
References & Citations
[1]J. Wang, et al., OA04.06 Efficacy and Safety of HS-20093 in Extensive Stage Small Cell Lung Cancer in A Multicenter, Phase 1 Study (ARTEMIS-001) . Volume 19, Issue 10, Supplement S17, 2024|[2]Lu Xie, et al., ARTEMIS-002: Phase 2 study of HS-20093 in patients with relapsed or refractory osteosarcoma. Journal of Clinical Oncology. 42 (16), 2024|[3]Jie Wang, et al., ARTEMIS-001: Phase 1 study of HS-20093, a B7-H3–targeting antibody-drug conjugate, in patients with advanced solid tumor. Journal of Clinical Oncology. 41 (16), 2023.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
031457-AP 200 µL
A2M, NT (A2M, CPAMD5, Alpha-2-macroglobulin, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5) (AP) discontinued
Sign In for Pricing
View Details